rts logo

Here is a breakdown of major shareholders in Virpax Pharmaceuticals Inc (NASDAQ: VRPX)

Virpax Pharmaceuticals Inc (NASDAQ: VRPX) is -36.96% lower on its value in year-to-date trading and has touched a low of $0.23 and a high of $5.48 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The VRPX stock was last observed hovering at around $0.25 in the last trading session, with the day’s loss setting it -0.01%.

Currently trading at $0.24, the stock is -15.76% and -25.22% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.2 million and changing -2.28% at the moment leaves the stock -65.87% off its SMA200. VRPX registered -92.91% loss for a year compared to 6-month loss of -71.91%.

The stock witnessed a -13.85% gain in the last 1 month and extending the period to 3 months gives it a -59.39%, and is -13.66% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.43% over the week and 13.91% over the month.

Virpax Pharmaceuticals Inc (VRPX) has around 7 employees, a market worth around $4.39M and $0.00M in sales. Distance from 52-week low is 4.13% and -95.63% from its 52-week high.

The shares outstanding are 18.34M, and float is at 18.04M with Short Float at 3.50%.

The top institutional shareholder in the company is PARALLEL ADVISORS, LLC with over 1.0 shares valued at $$1.0. The investor’s holdings represent 0.0001 of the VRPX Shares outstanding.

Related Posts